What is he best known for?
The fields of study he is best known for:
- Polymer
- Enzyme
- Organic chemistry
Fenghua Meng mostly deals with Micelle, Ethylene glycol, Drug delivery, Polymer chemistry and Drug carrier.
His Micelle research is multidisciplinary, incorporating perspectives in Copolymer, Targeted drug delivery and Dithiothreitol.
His Ethylene glycol research includes elements of Polyester, Hydrolysis, Intracellular and Nuclear chemistry.
His studies deal with areas such as Polymersome and Biophysics as well as Drug delivery.
While the research belongs to areas of Polymer chemistry, Fenghua Meng spends his time largely on the problem of Polymerization, intersecting his research to questions surrounding Biodegradable polymer.
As a member of one scientific family, Fenghua Meng mostly works in the field of Drug carrier, focusing on Caprolactone and, on occasion, Dynamic light scattering and Polycaprolactone.
His most cited work include:
- Stimuli-responsive polymersomes for programmed drug delivery. (869 citations)
- Reduction-sensitive polymers and bioconjugates for biomedical applications. (852 citations)
- Glutathione-responsive nano-vehicles as a promising platform for targeted intracellular drug and gene delivery. (836 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of study are Polymersome, Polymer chemistry, Ethylene glycol, Micelle and Biophysics.
His Polymersome research is multidisciplinary, relying on both Cancer research, Liposome, Doxorubicin Hydrochloride, Vesicle and Bovine serum albumin.
The concepts of his Polymer chemistry study are interwoven with issues in Copolymer, Polymerization, Polymer, Monomer and Drug carrier.
His work in Ethylene glycol covers topics such as Nuclear chemistry which are related to areas like Dynamic light scattering and Pulmonary surfactant.
His Micelle study combines topics from a wide range of disciplines, such as Paclitaxel, Drug delivery, Cytotoxicity and Doxorubicin.
His studies in Biophysics integrate themes in fields like Biochemistry, Intracellular and Glioma.
He most often published in these fields:
- Polymersome (25.70%)
- Polymer chemistry (25.23%)
- Ethylene glycol (23.83%)
What were the highlights of his more recent work (between 2017-2021)?
- Cancer research (16.82%)
- Polymersome (25.70%)
- In vitro (13.55%)
In recent papers he was focusing on the following fields of study:
His primary areas of investigation include Cancer research, Polymersome, In vitro, Chemotherapy and IC50.
His research integrates issues of Cancer cell, Cell, Cytotoxicity and Doxorubicin in his study of Cancer research.
His work carried out in the field of Polymersome brings together such families of science as Tetrahydrofuran, Ethylene glycol, Biophysics, Targeted therapy and Peptide.
His Ethylene glycol research incorporates themes from Copolymer and Polymerization.
As a part of the same scientific family, Fenghua Meng mostly works in the field of In vitro, focusing on Trimethylene carbonate and, on occasion, Dispersity, Monomer, Dithiolane, Molar mass and Polymer chemistry.
His research in Micelle intersects with topics in Nanotechnology, Drug delivery and Nanomedicine.
Between 2017 and 2021, his most popular works were:
- Apolipoprotein E Peptide-Directed Chimeric Polymersomes Mediate an Ultrahigh-Efficiency Targeted Protein Therapy for Glioblastoma. (44 citations)
- Highly efficacious and specific anti-glioma chemotherapy by tandem nanomicelles co-functionalized with brain tumor-targeting and cell-penetrating peptides. (40 citations)
- Protein Toxin Chaperoned by LRP-1-Targeted Virus-Mimicking Vesicles Induces High-Efficiency Glioblastoma Therapy In Vivo. (35 citations)
In his most recent research, the most cited papers focused on:
- Polymer
- Enzyme
- Biochemistry
The scientist’s investigation covers issues in Cancer research, Polymersome, Blood–brain barrier, IC50 and In vitro.
The study incorporates disciplines such as Cell, Chemotherapy, Doxorubicin, Cancer cell and Intracellular in addition to Cancer research.
His research in Cancer cell focuses on subjects like Pharmacokinetics, which are connected to Liposome.
His Polymersome research incorporates elements of Doxorubicin Hydrochloride, Biophysics, Vesicle, Ethylene glycol and Peptide.
Fenghua Meng works mostly in the field of IC50, limiting it down to topics relating to Cell-penetrating peptide and, in certain cases, Methotrexate, Internalization, Granzyme B, Methotrexate Sodium and Tumor progression, as a part of the same area of interest.
His In vitro study incorporates themes from Transfection and Gene delivery.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
